PET, PSMA, radiotracer, SNMMI 2015, prostate cancer

A new molecular imaging agent has been demonstrated to find prostate cancer that has spread to other tissues by locking in on the prostate specific membrane antigen (PSMA) enzyme, according to a new study. Results were presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

The latest advances in cardiovascular echocardiography will be presented at the 2015 American Society of Echocardiography (ASE) annual meeting June 12-16 in Boston. Several companies are making big announcements about new software and hardware.

non-Hodgkins lymphoma, PET/CT, recurrence, SNMMI 2015

Post-treatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment for non-Hodgkin lymphoma (NHL), said researchers at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

 

Endovascular treatment (EVT) of intracranial aneurysm is effective in preventing long-term bleeding, but may be followed by aneurysm recurrences in a significant proportion of cases, according to a study published online in the journal Radiology.

STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI

Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 

Scientists at Duke Medicine have produced a 3-D map of the human brain stem at an unprecedented level of detail using magnetic resonance imaging (MRI) technology.

At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore Convention Center, Siemens Healthcare debuted new technologies designed to expand the capabilities and improve the productivity of molecular imaging. Symbia Evo, Siemens' new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients and improve workflow efficiency.

ImagineSoftware will be exhibiting at the Radiology Business Management Association (RBMA) 2015 Radiology Summit Conference, June 7-10 at Caesar's Palace Hotel and Casino in Las Vegas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now